p.152 抽出テキスト

ripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies. Circ Res 2017; 120: 1326-1340. PMID: 28096194 718. Glaser JD, Bensley RP, Hurks R, et al. Fate of the contralateral limb after lower extremity amputation. J Vasc Surg 2013; 58: 1571-1577. PMID: 23921246 719. Bradley L, Kirker SG. Secondary prevention of arteriosclerosis in lower limb vascular amputees: A missed opportunity. Eur J Vasc Endovasc Surg 2006; 32: 491-493. PMID: 16934502 720. Waton S, Johal A, Heikkela K, et al. National Vascular Registry: 2016 annual report. Vascular Society of Great Britain and Ireland, 2016. 721. Abou-Zamzam AM Jr, Teruya TH, Killeen JD, et al. Major lower extremity amputation in an academic vascular center. Ann Vasc Surg 2003; 17: 86-90. PMID: 12522704 722. Slovut DP, Sullivan TM. Critical limb ischemia: medical and surgical management. Vasc Med 2008; 13: 281-291. PMID: 18687766 723. Baghdasaryan PA, Bae JH, Yu W, et al. “The renal foot” - Angiographic pattern of patients with chronic limb threatening ischemia and end-stage renal disease. Cardiovasc Revasc Med 2020; 21: 118- 121. PMID: 31575468 724. Desai TR, Meyerson SL, Skelly CL, et al. Patency and limb salvage after infrainguinal bypass with severely compromised (“blind”) outflow. Arch Surg 2001; 136: 635-642. PMID: 11386999 725. Biancari F, Albäck A, Ihlberg L, et al. Angiographic runoff score as a predictor of outcome following femorocrural bypass surgery. Eur J Vasc Endovasc Surg 1999; 17: 480-485. PMID: 10375483 726. Higashimori A, Iida O, Yamauchi Y, et al. OLIVE Investigators. Outcomes of One straight-line flow with and without pedal arch in patients with critical limb ischemia. Catheter Cardiovasc Interv 2016; 87: 129-133. PMID: 26489531 727. Kawarada O, Yasuda S, Huang J, et al. Contemporary infrapopliteal intervention for limb salvage and wound healing - Harmonization of revascularization and wound management. Circ J 2014; 78: 1540- 1549. PMID: 24964979 728. Uçkay I, Aragón-Sánchez J, Lew D, et al. Diabetic foot infections: what have we learned in the last 30 years? Int J Infect Dis 2015; 40: 81-91. PMID: 26460089 729. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-228. PMID: 15644549 730. Oresanya L, Zhao S, Gan S, et al. Functional outcomes after lower extremity revascularization in nursing home residents: A national cohort study. JAMA Intern Med 2015; 175: 951-957. PMID: 25844523 731. Bertges DJ, Neal D, Schanzer A, et al. The Vascular Quality Initiative Cardiac Risk Index for prediction of myocardial infarction after vascular surgery. J Vasc Surg 2016; 64: 1411-1421. PMID: 27449347 732. Suckow BD, Goodney PP, Cambria RA, et al. Vascular Study Group of New England. Predicting functional status following amputation after lower extremity bypass. Ann Vasc Surg 2012; 26: 67-78. PMID: 22176876 733. Schanzer A, Goodney PP, Li Y, et al. Vascular Study Group of Northern New England. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg 2009; 50: 769-775. PMID: 19628361 734. Klaphake S, de Leur K, Mulder PG, et al. Mortality after major amputation in elderly patients with critical limb ischemia. Clin Interv Aging 2017; 12: 1985-1992. PMID: 29200838 735. Suckow BD, Goodney PP, Nolan BW, et al. Domains that determine quality of life in vascular amputees. Ann Vasc Surg 2015; 29: 722- 730. PMID: 25725279 736. Columbo JA, Davies L, Kang R, et al. Patient experience of recovery after major leg amputation for arterial disease. Vasc Endovascular Surg 2018; 52: 262-268. PMID: 29495957 737. Stern JR, Wong CK, Yerovinkina M, et al. A Meta-analysis of Longterm Mortality and Associated Risk Factors following Lower Extremity Amputation. Ann Vasc Surg 2017; 42: 322-327. PMID: 28389295 738. van Netten JJ, Fortington LV, Hinchliffe RJ, et al. Early Post-operative Mortality After Major Lower Limb Amputation: A Systematic Review of Population and Regional Based Studies. Eur J Vasc Endovasc Surg 2016; 51: 248-257. PMID: 26588994 739. Ogaki T, Iida O, Hata Y, et al. The perioperative and long-term fates of patients with chronic limb-threatening ischaemia who underwent secondary major amputations. Int Wound J 2022; 19: 36-43. PMID: 33998127 740. 辻依子,寺師浩人,田原真也.重症下肢虚血患者における下肢切

断レベルによる歩行機能への影響.日形会誌 2010;30:670-677. 741. Dillingham TR, Pezzin LE, Shore AD. Reamputation, mortality, and

health care costs among persons with dysvascular lower-limb amputations. Arch Phys Med Rehabil 2005; 86: 480-486. PMID: 15759232 742. Kono Y, Muder RR. Identifying the incidence of and risk factors for reamputation among patients who underwent foot amputation. Ann Vasc Surg 2012; 26: 1120-1126. PMID: 22840342 743. Beaulieu RJ, Grimm JC, Lyu H, et al. Rates and predictors of readmission after minor lower extremity amputations. J Vasc Surg 2015; 62: 101-105. PMID: 25827965 744. Taylor SM, Kalbaugh CA, Cass AL, et al. “Successful outcome” after below-knee amputation: an objective definition and influence of clinical variables. Am Surg 2008; 74: 607-613. PMID: 18646478 745. O’Brien PJ, Cox MW, Shortell CK, et al. Risk factors for early failure of surgical amputations: an analysis of 8,878 isolated lower extremity amputation procedures. J Am Coll Surg 2013; 216: 836-842. PMID: 23521969 746. Waton S, Johal A, Heikkela K, et al. National Vascular Registry: 2015 annual report. Vascular Society of Great Britain and Ireland, 2015. 747. Inderbitzi R, Buettiker M, Enzler M. The long-term mobility and mortality of patients with peripheral arterial disease following bilateral amputation. Eur J Vasc Endovasc Surg 2003; 26: 59-64. PMID: 12819649 748. Hoffmann M, Kujath P, Flemming A, et al. Survival of diabetes patients with major amputation is comparable to malignant disease. Diab Vasc Dis Res 2015; 12: 265-271. PMID: 25920914 749. Ambler GK, Thomas-Jones E, Edwards AGK, et al. Prognostic Risk Modelling for Patients Undergoing Major Lower Limb Amputation: An Analysis of the UK National Vascular Registry. Eur J Vasc Endovasc Surg 2020; 59: 606-613. PMID: 31883800 750. Leon MB, Baim DS, Popma JJ, et al. Stent Anticoagulation Restenosis Study Investigators. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998; 339: 1665-1671. PMID: 9834303 751. Strobl FF, Brechtel K, Schmehl J, et al. Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease. J Endovasc Ther 2013; 20: 699-706. PMID: 24093324 752. Iida O, Yokoi H, Soga Y, et al. STOP-IC investigators. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study. Circulation 2013; 127: 2307-2315. PMID: 23652861 753. Miura T, Miyashita Y, Soga Y, et al. Drug-Eluting Versus Bare-Metal Stent Implantation With or Without Cilostazol in the Treatment of the Superficial Femoral Artery: The DEBATE in SFA Study Circ Cardiovasc Interv 2018; 11: e006564. PMID: 30354784 754. Iida O, Soga Y, Urasawa K, et al. MDT-2113 SFA Japan Investigators. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial. J Endovasc Ther 2018; 25: 109-117. PMID: 29264999 755. Dake MD, Ansel GM, Jaff MR, et al. Zilver PTX Investigators. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: Twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 2011; 4: 495- 504. PMID: 21953370 756. Gray WA, Keirse K, Soga Y, et al. IMPERIAL investigators. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet 2018; 392: 1541-1551. PMID: 30262332 757. Iida O, Takahara M, Soga Y, et al. 1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis. JACC Cardiovasc Interv 2015; 8: 1105-1112. PMID: 26117463 758. Yokoi H, Ohki T, Kichikawa K, et al. Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 12-Month Results. JACC Cardiovasc Interv 2016; 9: 271-277. PMID: 26847118 759. Bedenis R, Lethaby A, Maxwell H, et al. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev 2015: CD000535. PMID: 25695213 760. Belch JJ, Dormandy J, et al. CASPAR Writing Committee. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 2010; 52: 825-833. PMID: 20678878 761. Sarac TP, Huber TS, Back MR, et al. Warfarin improves the out-